Ryohei Ogawa

Title: Ryohei Ogawa: Innovator in Vaccine Development

Introduction

Ryohei Ogawa is a notable inventor based in East Lansing, MI (US). He has made significant contributions to the field of vaccine development, particularly in the area of avian health. His work has implications for the poultry industry and animal health.

Latest Patents

Ogawa holds a patent for a recombinant fowlpox vaccine designed to protect against Marek's disease. This innovative vaccine utilizes a recombinant fowlpox virus that contains genes for various Marek's Disease Virus antigens. These antigens include glycoprotein B homologue, glycoprotein C homologue, glycoprotein D homologue, glycoprotein H homologue, and tegument proteins. The genes are placed under the control of a poxvirus promoter within a non-essential region of the fowlpox virus DNA, enhancing the vaccine's effectiveness.

Career Highlights

Throughout his career, Ogawa has worked with prominent organizations, including Nippon Zeon Company, Ltd. and The United States of America as Represented by the Secretary of Agriculture. His experience in these institutions has contributed to his expertise in vaccine research and development.

Collaborations

Ogawa has collaborated with notable colleagues such as Lucy F. Lee and Noboru Yanagida. These partnerships have likely enriched his research and expanded the impact of his innovations.

Conclusion

Ryohei Ogawa's contributions to vaccine development, particularly through his recombinant fowlpox vaccine, highlight his role as an innovator in the field. His work not only advances scientific knowledge but also has practical applications in protecting avian health.